![]() |
CUPERTINO, Calif., Dec. 16, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128)
today revealed encouraging results from an exploratory clinical... Cancer immunotherapy, Clinical trial, Microbio Co., Ltd., Pembrolizumab, Stage IIIB Non-Small Cell Lung Cancer |
More about this | |
|
|
|